Lamivudine treatment of chronic hepatitis B 36 cases.docVIP

 PAGE \* MERGEFORMAT 7 Lamivudine treatment of chronic hepatitis B 36 cases [Abstract] Objective To observe the clinical lamivudine in the treatment of chronic hepatitis B patients. Methods 72 patients with chronic hepatitis B were randomly divided into two groups and the control group 36 patients in the control group were given a 2 b interferon intramuscular injection, once a 3 months in the observation group to lamivudine orally, once every 12 months. Results observation group and the efficiency of the control group was 44.4%, respectively, and 13.9%, the difference was statistically significant (P lt;0.01), observed group, 61.1% of the total effective rate is also higher than 33.3% (P lt;0.05). two negative rate of HBeAg and HBV DNA was no significant difference (Pgt; 0.05). Conclusion Lamivudine treatment of chronic hepatitis B Hepatitis safe and effective drug. [Keywords:] chronic hepatitis B, lamivudine, a interferon [Abstract] Objective To observe the clinical efficacy of lamivudine for the treatment of chronic hepatitis B. Methods 72 cases were randomly divided into the observation group (n = 36) and control group (n = 36). Control group were treated by “INF a “with a course of 3 months.observation group were treated by” lamivudine “with a course of 12 months. Results The markedly effective rate of treatment group was significantly higher than that of control group (44.4% vs 13.9%, P lt;0.01 ). The total effective rate of treatment group was significantly higher than that of control group (61.1% vs 33.3%, P lt;0.05) too.There were no significant differences in the rates for HBeAg and HBV DNA to change to negative between the two groups (Pgt; 0.05). Conclusion Lamivudine is effective and safe in treatment of cases with chronic hepatitis B. [Keywords:] Chronic hepatitis B, Lamivudine, INF a Delayed healing of chronic illness is the root cause of viral replication, thus inhibiting the treatment of hepatitis B virus replication is the key. La